1Oelkers P,Behari A,Cromley.Characterization of two human genes encoding acyl coenzyme A:cholesterol acyltransferase-related enzymes[J].J Biol Chem,1998,273:26765.
2Song BL,Qi W,Yang XY,et a1.Organization of human ACAT-2 gene and its cell type-specific promoter activity [J].Biochem Biophy Res Commun,2001,282:580.
3Song BL,Qi W,Wang CH,et a1.Preparation of an anti-Cdx-2 antibody for analysis of different species Cdx-2 binding to acat2 promoter[J].Acat Biochimica Biophysica Sinica,2003,35(1):6.
4Rudel LI。,Lee RG,Cockman TL.Acyl coenzyme A:cholesterol acyltransferase types 1 and 2:structure and function in atherosclerosis[J].Curr Opin Lipidol,2001,12:121.
5Joyce CW,Shelness GS,Davis MA,et a1.ACATl and ACAT2 membrane topology segregates a serine residue essential for activity to opposite sides of the endoplasmic reticulum membrane[J].Mol Biol Cell,2000,11:3675.
6Chang CCY,Sakashita N,Ornvold Kim.et a1.Immunological quantitation and localization of ACAT-1 and ACAT-2in human liver and small intestine[J].J Biol Chem,2000,275:28083.
7Wilcox IJ,Borradaile NM,Dreu LE,et a1.Secretion of hepatocyte apoB is inhibited by the flavonoids,naringenin and hesperetin,via reduced activity and expression ofACAT2 and MTP[J].J Lipid Res,2001,42:725.
8Sakashita N,Miyazaki A,Chang CCY,et a1.Acyl—coenzyme A:cholesterol acyltransferase 2(ACAT2)is inducedin monocyte-derived macrophages:in vivo and in vitrostudies[J].Lab Invest,2003,83:1 569.
9Temel RE,Gebre AK,Parks JS,et a1.Compared with acyl—CoA:cholesterol O-acyhransferase(ACAT)1 and lecithin:cholesterol acyltransferase,ACAT2 displays the greatest capacity to differentiate cholesterol from sitoster—ol[J].J Biol Chem,2003,278:47594.
10Duggirala R,Blangero J,Almasy L,et a1.A major locus for fasting insulin concentrations and insulin resistance on chromosome 6q with strong pleiotropic effects on obesityrelated phenotypes in nondiabetic Mdxican Americans[J].Am J Hum Genet,2001,68:1149.
3kamanna VS, Roh DD, Kirschcnbauto MA. Atherogenic lipoprotein S: mediaters of glomertular injury [editorial][J]. Am J Nephrol,1993,13:1
4Scheer WD,Budreall DA, Malcon GT,et al. Apolipoprotein E and atherosclerosis in Alaska NatiVe[J]. Atherosclerosis, 1995,114:197
5Semti M,Romero R,Pedro-Boretj, et al. Lipoprotein abnomalities in hyperlipidemic and normolipidemic medn on hemodialysis with chronic renal failure[J]. Kidney Int,1992,41:1394
6Horita D, Eto M,Makino I. Apolipoprotein E2,renal failure and lipid abnormalities in non-insulin-dependent diabetes mellitus[J]. Atherosclreosis, 1994,107:203
7Woolf B. On estimating the relation between blood group and disease[J]. Ann Hum Genet, 1995,19: 251
8Tan CE, Tai ES, Tan CS, et al. Apo E polymorphism and lipid profile in three ethnic group in Singapore population[J]. Atherosclerosis, 2003 ; 170: 253
9Kataoka S,Robbins DC,Cowan LD,et al. Apolipoprotein E polymorphism in American Indians and its relation to plasma lipoprotein and diabetes. The Strong Heart Study[J]. Arterioscler Thromb Vasc Biol, 1996,16: 918
